Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

CMS Subsidiary Rxilient Medical Wins Singapore HSA Approval for Lumirix in Vitiligo – First Regional Indication Expansion for the Topical JAK Inhibitor Licensed from Incyte
CompanyDrug

CMS Subsidiary Rxilient Medical Wins Singapore HSA Approval for Lumirix in Vitiligo – First Regional Indication Expansion for the Topical JAK Inhibitor Licensed from Incyte

China Medical System Holdings Limited (CMS) (HKG: 0867; SGX: 8A8) announced that its subsidiary, Rxilient Medical, has obtained approval from the Health Sciences Authority (HSA) of Singapore for a new…

CSPC Pharmaceutical Initiates Phase II Trial of SYH2072 – Self‑Developed Aldosterone Synthase Inhibitor Targeting Uncontrolled and Refractory Hypertension in China

CSPC Pharmaceutical Initiates Phase II Trial of SYH2072 – Self‑Developed Aldosterone Synthase Inhibitor Targeting Uncontrolled and Refractory Hypertension in China

Zuellig Pharma Acquires Licensed Pharmaceutical Entity and Facility in Hangzhou, China – Strategic Move Strengthens Clinical Trial Sourcing Capabilities

Zuellig Pharma Acquires Licensed Pharmaceutical Entity and Facility in Hangzhou, China – Strategic Move Strengthens Clinical Trial Sourcing Capabilities

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

BioRay Pharmaceutical’s Zuberitamab Approved by NMPA for CD20 Positive DLBCL Treatment

CompanyDrug

CARSgen Therapeutics Initiates Phase II Study for CT041 in Advanced Gastric Cancer

CompanyDeals

HitGen Inc. Enters Research Agreement with ARase Therapeutics to Discover Oncology Inhibitors

CompanyDrug

Antengene Submits Market Approval Filing for Xpovio in Indonesia for Multiple Myeloma and Lymphoma

CompanyDrug

TYK Medicines Receives CDE Approval for CDK7 Inhibitor TY-2699a Clinical Study

CompanyDrug

BeiGene’s Tislelizumab Secures First Approvals Outside China Mainland in Macau

CompanyDrug

Yizun Biomedicine’s CNK-UT Cell Therapy Initiates Patient Enrollment for Solid Tumor Trial

CompanyDrug

Zelgen Biopharmaceuticals’ ZG0895 Receives FDA Approval for Clinical Trials in Advanced Solid Tumors

Show More